One alternative to antibiotics is phage therapy, which harnesses viruses to attack bacterial cells. Conceived over a century ...

Blue Cross and Blue Shield of Kansas City denied covering the cost of a metro woman’s medicine that could save her life ...

As state-level bans on youth gender medicine have accumulated, and are being tested at the Supreme Court, this controversial ...

Mark Cuban’s Cost Plus Drugs marketplace company is designed to help hospitals and health systems source generic drugs from ...

Insilico Medicine (“Insilico”), a clinical-stage generative artificial intelligence (AI)-driven drug discovery company, today ...

Prime Medicine已经花费数年时间开发其平台，现在正将重点转向推进预计在2025年及以后达到价值拐点的关键项目。该公司的分析表明，目前的股价由公司针对Wilson病的项目支撑，这意味着管线中其余部分存在相当大的未开发价值。

Chief medical correspondent Dr. Jon LaPook joins "CBS Mornings Plus" to discuss the impact of artificial intelligence in ...

In industry parlance, the deal joins a “delivery” company with a “cargo” company — fusing the two key pieces needed to build ...

China's "God of Medicine" celebrated his 100th birthday on Saturday, when a play about the life of Dr Wang Zhenyi was staged ...

马萨诸塞州剑桥市——Editas Medicine, Inc.（纳斯达克股票代码：EDIT）的首席执行官Gilmore O'Neill最近出售了1,618股公司普通股。这笔交易发生在2024年12月3日，以每股2.0774美元的加权平均价格执行，总销售价值约为3,361美元。根据 InvestingPro 的数据，在股票交易接近52周低点之际进行了此次出售，该股票年初至今已下跌超过80%。